Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 715,000 | 923,000 | 816,000 | 779,000 | 603,000 |
| Cost of Goods | 42,000 | 48,000 | 40,000 | 28,000 | 27,000 |
| Gross Profit | 673,000 | 875,000 | 776,000 | 751,000 | 576,000 |
| Operating Expenses | 485,000 | 565,000 | 466,000 | 515,000 | 460,000 |
| Operating Income | 188,000 | 310,000 | 310,000 | 236,000 | 116,000 |
| Interest Expense | 45,000 | 109,000 | 101,000 | 46,000 | 35,000 |
| Other Income | 101,000 | 316,000 | 44,000 | 117,000 | 168,000 |
| Pre-tax Income | 244,000 | 517,000 | 253,000 | 307,000 | 249,000 |
| Income Tax | 49,000 | -35,000 | 67,000 | 104,000 | 57,000 |
| Net Income Continuous | 195,000 | 552,000 | 186,000 | 203,000 | 192,000 |
| Net Income | $195,000 | $552,000 | $186,000 | $203,000 | $192,000 |
| EPS Basic Total Ops | 3.06 | 8.61 | 2.94 | 3.15 | 2.96 |
| EPS Basic Continuous Ops | 3.06 | 8.60 | 2.94 | 3.15 | 2.96 |
| EPS Diluted Total Ops | 3.05 | 8.54 | 2.92 | 3.13 | 2.94 |
| EPS Diluted Continuous Ops | 3.05 | 8.53 | 2.92 | 3.13 | 2.94 |
| EPS Diluted Before Non-Recurring Items | 3.05 | 5.70 | 2.92 | N/A | N/A |
| EBITDA(a) | $204,000 | $327,000 | $326,000 | $250,000 | $129,000 |